Lumida
/DAWN
⌘K
Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

DAWN
$21.53USD+0.19%+0.04 today

MARKET CAP

2.2B

P/E (TTM)

FWD P/E

DAY RANGE

$21 – $22

52W RANGE

$6
$22

AI Summary

Stalk
StalkMedium

DAWN remains in Stage 2 Advancing with robust parabolic trend acceleration but is highly extended above steeply rising EMAs without clear pullback, making immediate execution unfavorable. Under a speculative strategy requiring distinct asymmetry, execution is deferred until a constructive retracement into rising EMA or support zones emerges. Medium-term bias stays bullish, but timing awaits a defined pullback for a higher probability entry.

  • Ojemda net revenue $155.4M (+172% YoY) in 2025
  • Prescriptions >4,600 (+180% YoY), up 15% QoQ
  • Sustaining adoption may falter due to entrenched therapy use
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income